Shanghai Tofflon Science Tech (300171) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Tofflon Science Tech (300171) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥47.30 Million ≈ $6.92 Million USD) by net assets (CN¥8.09 Billion ≈ $1.18 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Shanghai Tofflon Science Tech worth for the company's overall valuation and market capitalisation.
Shanghai Tofflon Science Tech - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Shanghai Tofflon Science Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Tofflon Science Tech Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Tofflon Science Tech ranked by their cash flow conversion efficiency. Explore Shanghai Tofflon Science Tech cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vericel Corp Ord
NASDAQ:VCEL
|
0.042x |
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
-0.065x |
|
Believe SAS
PA:BLV
|
0.049x |
|
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238
|
0.027x |
|
Husqvarna AB (publ)
ST:HUSQ-B
|
0.146x |
|
DTR Automotive
KO:007340
|
0.063x |
|
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
|
0.048x |
|
Fortress Income Fund Ltd
JSE:FFB
|
0.032x |
Annual Cash Flow Conversion Efficiency for Shanghai Tofflon Science Tech (2007–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Tofflon Science Tech from 2007 to 2024. View 300171 share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.05 Billion ≈ $1.18 Billion |
CN¥880.61 Million ≈ $128.86 Million |
0.109x | +384.10% |
| 2023-12-31 | CN¥8.11 Billion ≈ $1.19 Billion |
CN¥-312.38 Million ≈ $-45.71 Million |
-0.039x | -219.14% |
| 2022-12-31 | CN¥7.64 Billion ≈ $1.12 Billion |
CN¥247.15 Million ≈ $36.17 Million |
0.032x | -89.42% |
| 2021-12-31 | CN¥4.48 Billion ≈ $655.32 Million |
CN¥1.37 Billion ≈ $200.32 Million |
0.306x | +1.20% |
| 2020-12-31 | CN¥3.69 Billion ≈ $540.54 Million |
CN¥1.12 Billion ≈ $163.28 Million |
0.302x | +119.46% |
| 2019-12-31 | CN¥3.24 Billion ≈ $474.49 Million |
CN¥446.31 Million ≈ $65.31 Million |
0.138x | +93.23% |
| 2018-12-31 | CN¥3.12 Billion ≈ $456.14 Million |
CN¥222.04 Million ≈ $32.49 Million |
0.071x | +950.96% |
| 2017-12-31 | CN¥3.09 Billion ≈ $451.60 Million |
CN¥20.92 Million ≈ $3.06 Million |
0.007x | -81.07% |
| 2016-12-31 | CN¥3.00 Billion ≈ $438.97 Million |
CN¥107.41 Million ≈ $15.72 Million |
0.036x | -24.96% |
| 2015-12-31 | CN¥2.95 Billion ≈ $431.38 Million |
CN¥140.66 Million ≈ $20.58 Million |
0.048x | +131.95% |
| 2014-12-31 | CN¥2.68 Billion ≈ $391.66 Million |
CN¥55.06 Million ≈ $8.06 Million |
0.021x | -85.39% |
| 2013-12-31 | CN¥2.41 Billion ≈ $352.36 Million |
CN¥338.95 Million ≈ $49.60 Million |
0.141x | -9.76% |
| 2012-12-31 | CN¥2.23 Billion ≈ $325.86 Million |
CN¥347.38 Million ≈ $50.83 Million |
0.156x | +185.77% |
| 2011-12-31 | CN¥2.08 Billion ≈ $304.19 Million |
CN¥113.47 Million ≈ $16.60 Million |
0.055x | -84.69% |
| 2010-12-31 | CN¥331.97 Million ≈ $48.58 Million |
CN¥118.39 Million ≈ $17.32 Million |
0.357x | -36.58% |
| 2009-12-31 | CN¥211.83 Million ≈ $31.00 Million |
CN¥119.11 Million ≈ $17.43 Million |
0.562x | +47.46% |
| 2008-12-31 | CN¥147.32 Million ≈ $21.56 Million |
CN¥56.17 Million ≈ $8.22 Million |
0.381x | +34.11% |
| 2007-12-31 | CN¥113.69 Million ≈ $16.64 Million |
CN¥32.32 Million ≈ $4.73 Million |
0.284x | -- |
About Shanghai Tofflon Science Tech
Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laborato… Read more